LakeShore Biopharma Co., Ltd (LSB)
NASDAQ: LSB · Real-Time Price · USD
0.8305
-0.0470 (-5.36%)
At close: Sep 12, 2025, 4:00 PM EDT
0.8020
-0.0285 (-3.43%)
After-hours: Sep 12, 2025, 6:57 PM EDT
LakeShore Biopharma Market Cap
LakeShore Biopharma has a market cap or net worth of $34.23 million as of September 12, 2025. Its market cap has decreased by -59.40% in one year.
Market Cap
34.23M
Enterprise Value
87.46M
1-Year Change
-59.40%
Ranking
Category
Stock Price
0.83
Market Cap Chart
Since August 5, 2021, LakeShore Biopharma's market cap has decreased from $227.76M to $34.23M, a decrease of -84.97%. That is a compound annual growth rate of -36.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 34.23M | -48.16% |
| Dec 31, 2024 | 66.02M | 38.83% |
| Dec 29, 2023 | 47.55M | -80.26% |
| Dec 30, 2022 | 240.85M | 3.14% |
| Dec 29, 2021 | 233.52M | 2.53% |
| Aug 5, 2021 | 227.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.94B |
| Johnson & Johnson | 429.89B |
| AbbVie | 389.03B |
| UnitedHealth Group | 320.26B |
| AstraZeneca | 251.66B |
| Novartis AG | 247.58B |
| Novo Nordisk | 241.70B |
| Abbott Laboratories | 230.87B |